| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:43 UTC |
|---|
| HMDB ID | HMDB0014744 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cyclothiazide |
|---|
| Description | As a diuretic, cyclothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like cyclothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of cyclothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. |
|---|
| Structure | NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2 InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20) |
|---|
| Synonyms | | Value | Source |
|---|
| 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | ChEBI | | 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide | ChEBI | | 6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | ChEBI | | 6-Chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide | ChEBI | | Ciclotiazida | ChEBI | | Cyclothiazidum | ChEBI | | Anhydron | Kegg | | 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulphonamide 1,1-dioxide | Generator | | 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulphamoyl-1,2,4-benzothiadiazine 1,1-dioxide | Generator | | 6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulphonamide 1,1-dioxide | Generator | | 6-Chloro-3-(2-norbornen-5-yl)-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide | Generator | | Ciclotiazide | HMDB |
|
|---|
| Chemical Formula | C14H16ClN3O4S2 |
|---|
| Average Molecular Weight | 389.878 |
|---|
| Monoisotopic Molecular Weight | 389.027075102 |
|---|
| IUPAC Name | 3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide |
|---|
| Traditional Name | cyclothiazide |
|---|
| CAS Registry Number | 2259-96-3 |
|---|
| SMILES | NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2 |
|---|
| InChI Identifier | InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20) |
|---|
| InChI Key | BOCUKUHCLICSIY-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2,4-benzothiadiazine-1,1-dioxides. These are aromatic heterocyclic compounds containing a 1,2,4-benzothiadiazine ring system with two S=O bonds at the 1-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Thiadiazines |
|---|
| Sub Class | Benzothiadiazines |
|---|
| Direct Parent | 1,2,4-benzothiadiazine-1,1-dioxides |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2,4-benzothiadiazine-1,1-dioxide
- Secondary aliphatic/aromatic amine
- Aryl chloride
- Aryl halide
- Organosulfonic acid amide
- Benzenoid
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Aminosulfonyl compound
- Sulfonyl
- Secondary amine
- Azacycle
- Organic oxide
- Amine
- Organopnictogen compound
- Organosulfur compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 227 - 228 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.28 g/L | Not Available | | LogP | 1.6 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.36 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.2405 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.28 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 33.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1928.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 267.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 130.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 179.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 116.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 401.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 496.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 348.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 997.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 368.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1209.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 311.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 356.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 392.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 296.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 188.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Cyclothiazide,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3656.1 | Semi standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3371.2 | Standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4671.0 | Standard polar | 33892256 | | Cyclothiazide,1TMS,isomer #2 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3548.1 | Semi standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #2 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3429.8 | Standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #2 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4851.3 | Standard polar | 33892256 | | Cyclothiazide,1TMS,isomer #3 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 3497.1 | Semi standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #3 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 3378.2 | Standard non polar | 33892256 | | Cyclothiazide,1TMS,isomer #3 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 5022.9 | Standard polar | 33892256 | | Cyclothiazide,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3519.3 | Semi standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3576.3 | Standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4637.7 | Standard polar | 33892256 | | Cyclothiazide,2TMS,isomer #2 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 3512.7 | Semi standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #2 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 3505.8 | Standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #2 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 4274.6 | Standard polar | 33892256 | | Cyclothiazide,2TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 3496.5 | Semi standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 3487.4 | Standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 4588.4 | Standard polar | 33892256 | | Cyclothiazide,2TMS,isomer #4 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 3414.0 | Semi standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #4 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 3527.7 | Standard non polar | 33892256 | | Cyclothiazide,2TMS,isomer #4 | C[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 4718.9 | Standard polar | 33892256 | | Cyclothiazide,3TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3442.9 | Semi standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3708.5 | Standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4207.8 | Standard polar | 33892256 | | Cyclothiazide,3TMS,isomer #2 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S1(=O)=O | 3485.7 | Semi standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #2 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S1(=O)=O | 3706.6 | Standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #2 | C[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S1(=O)=O | 4538.0 | Standard polar | 33892256 | | Cyclothiazide,3TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 3387.9 | Semi standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 3654.1 | Standard non polar | 33892256 | | Cyclothiazide,3TMS,isomer #3 | C[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C)S2(=O)=O | 4234.3 | Standard polar | 33892256 | | Cyclothiazide,4TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 3420.4 | Semi standard non polar | 33892256 | | Cyclothiazide,4TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 3875.1 | Standard non polar | 33892256 | | Cyclothiazide,4TMS,isomer #1 | C[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C)C1C1CC2C=CC1C2 | 4213.2 | Standard polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3921.4 | Semi standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 3634.1 | Standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4739.8 | Standard polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3835.8 | Semi standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 3662.0 | Standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4956.9 | Standard polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 3756.9 | Semi standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 3627.3 | Standard non polar | 33892256 | | Cyclothiazide,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(N)(=O)=O)C=C2S1(=O)=O | 5121.7 | Standard polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4031.5 | Semi standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4078.3 | Standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O | 4703.2 | Standard polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 4019.4 | Semi standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 4015.2 | Standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)NS2(=O)=O | 4349.7 | Standard polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 3942.8 | Semi standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 4023.9 | Standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)NC(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 4657.7 | Standard polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 3906.6 | Semi standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 4041.5 | Standard non polar | 33892256 | | Cyclothiazide,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(N)(=O)=O)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 4813.4 | Standard polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4165.8 | Semi standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4470.5 | Standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)NC1C1CC2C=CC1C2 | 4300.7 | Standard polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S1(=O)=O | 4128.8 | Semi standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S1(=O)=O | 4490.8 | Standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C2CC3C=CC2C3)NC2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S1(=O)=O | 4601.5 | Standard polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 4068.1 | Semi standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 4453.6 | Standard non polar | 33892256 | | Cyclothiazide,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC2=C(C=C1Cl)N([Si](C)(C)C(C)(C)C)C(C1CC3C=CC1C3)N([Si](C)(C)C(C)(C)C)S2(=O)=O | 4364.0 | Standard polar | 33892256 | | Cyclothiazide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 4299.9 | Semi standard non polar | 33892256 | | Cyclothiazide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 4908.6 | Standard non polar | 33892256 | | Cyclothiazide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C2=CC(Cl)=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2S(=O)(=O)N([Si](C)(C)C(C)(C)C)C1C1CC2C=CC1C2 | 4357.6 | Standard polar | 33892256 |
|
|---|